The Food and Drugs Authority (FDA) has withdrawn the marketing authorisation of Omama Herbal Mixture over regulatory non-compliance.
In a statement, the Authority explained that the product no longer meets the required standards for safety, quality, and efficacy. The FDA has therefore directed the manufacturer to halt distribution and advised the public to stop using the product immediately.
Consumers experiencing any adverse effects after using Omama Herbal Mixture are encouraged to report to the nearest FDA office or through the Authority’s online safety monitoring platforms.
The FDA reaffirmed its commitment to ensuring that all medicines and herbal products on the Ghanaian market are safe, effective, and properly registered.
